A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study

Type of Cancer
Lymphoma

Site
Hackensack

Sponsor
Janssen

Protocol Number
PCI32765CAN3001-EXT

To Learn More Call
201-510-0910